Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion

Tan,Feng; Fu,Wenjun; Cheng,Nanfang; Meng,Di; Gu,Yong

doi:10.3892/etm.2015.2365

Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion

Authors:
- Feng Tan
- Wenjun Fu
- Nanfang Cheng
- Di Meng
- Yong Gu
View Affiliations

Affiliations: Department of Neurology, Foshan Hospital of Traditional Chinese Medicine, Foshan, Guangdong 528000, P.R. China, College of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China, Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guandong 510515, P.R. China
Published online on: March 16, 2015 https://doi.org/10.3892/etm.2015.2365
Pages: 1757-1762

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ligustrazine, also known as 2,3,5,6‑tetramethylpyrazine (TMP), one of the major active compounds of Ligusticum wallichii Franchat., has been shown to reduce neuroinflammation and protect neurons during cerebral ischemia/reperfusion injury. However, whether it reduces blood‑brain barrier (BBB) permeability during ischemic stroke is unclear. The aim of the present study was to investigate the role that TMP plays in protecting the BBB integrity in ischemia/reperfusion injury and to investigate the relevant mechanisms involved. Rats received an intraperitoneal injection of 20 mg/kg TMP 15 min before the onset of ischemia, which was induced by middle cerebral artery occlusion. Infarct volume, neurological score, brain edema, BBB permeability and tight junction protein impairment were observed. The results showed that TMP reduced the neurological score and levels of brain infarction and edema. In addition, TMP significantly decreased BBB permeability and prevented the impairment of occludin and claudin‑5, two tight junction protein components of the BBB, in rat brains with ischemia/reperfusion injury. In addition, the expression and activity of matrix metalloproteinases, enzymes responsible for the degradation of the extracellular matrix and tight junctions, were reduced in the rat brains by TMP treatment. These results combined suggest that TMP reduces BBB permeability as well as neuronal damage in focal cerebral ischemia/reperfusion injury in rats.

View Figures

View References

1	Gu Y, Dee CM and Shen J: Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front Biosci (Schol Ed). 3:1216–1231. 2011. View Article : Google Scholar : PubMed/NCBI
2	Eltzschig HK and Eckle T: Ischemia and reperfusion - from mechanism to translation. Nat Med. 17:1391–1401. 2011. View Article : Google Scholar : PubMed/NCBI
3	Gu Y, Chen J and Shen J: Herbal medicines for ischemic stroke: Combating inflammation as therapeutic targets. J Neuroimmune Pharmacol. 9:313–339. 2014. View Article : Google Scholar : PubMed/NCBI
4	Obermeier B, Daneman R and Ransohoff RM: Development, maintenance and disruption of the blood-brain barrier. Nat Med. 19:1584–1596. 2013. View Article : Google Scholar : PubMed/NCBI
5	Han JZ, Sun J, Zhu QG, Liu JY, Hu JH and Chen F: A modified LC-MS/MS method for determination of tetramethylpyrazine in microdialysis samples and calibration of home-made linear probes. Biomed Chromatogr. 26:1276–1281. 2012. View Article : Google Scholar : PubMed/NCBI
6	Chun-sheng L, Hsiao-meng Y, Yun-hsiang H, Chun P and Chi-fen S: Radix Salviae Miltiorrhizae and Rhizoma Ligustici Wallichii in coronary heart disease. Chin Med J (Engl). 4:43–46. 1978.PubMed/NCBI
7	Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, Hu S, Gong G and Chen SY: Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett. 449:24–27. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kao TK, Ou YC, Kuo JS, Chen WY, Liao SL, Wu CW, Chen CJ, Ling NN, Zhang YH and Peng WH: Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int. 48:166–176. 2006. View Article : Google Scholar : PubMed/NCBI
9	Xiao X, Liu Y, Qi C, Qiu F, Chen X, Zhang J and Yang P: Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia. Neurol Res. 32:547–555. 2010. View Article : Google Scholar : PubMed/NCBI
10	Liao SL, Kao TK, Chen WY, Lin YS, Chen SY, Raung SL, Wu CW, Lu HC and Chen CJ: Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett. 372:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kao TK, Chang CY, Ou YC, Chen WY, Kuan YH, Pan HC, Liao SL, Li GZ and Chen CJ: Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp Neurol. 247:188–201. 2013. View Article : Google Scholar : PubMed/NCBI
12	Shih YH, Wu SL, Chiou WF, Ku HH, Ko TL and Fu YS: Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture. Neuroreport. 13:515–519. 2002. View Article : Google Scholar : PubMed/NCBI
13	Li SY, Jia YH, Sun WG, Tang Y, An GS, Ni JH and Jia HT: Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic Biol Med. 48:597–608. 2010. View Article : Google Scholar : PubMed/NCBI
14	Lu C, Zhang J, Shi X, Miao S, Bi L, Zhang S, Yang Q, Zhou X, Zhang M, Xie Y, et al: Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP. Int J Biol Sci. 10:350–357. 2014. View Article : Google Scholar : PubMed/NCBI
15	Leng YF, Gao XM, Wang SX and Xing YH: Effects of tetramethylpyrazine on neuronal apoptosis in the superficial dorsal horn in a rat model of neuropathic pain. Am J Chin Med. 40:1229–1239. 2012. View Article : Google Scholar : PubMed/NCBI
16	Fan LH, Wang KZ, Cheng B, Wang CS and Dang XQ: Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci. 7:482006. View Article : Google Scholar : PubMed/NCBI
17	Feng L, Ke N, Cheng F, Guo Y, Li S, Li Q and Li Y: The protective mechanism of ligustrazine against renal ischemia/reperfusion injury. J Surg Res. 166:298–305. 2011. View Article : Google Scholar : PubMed/NCBI
18	Chang Y, Hsiao G, Chen SH, Chen YC, Lin JH, Lin KH, Chou DS and Sheu JR: Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol Sin. 28:327–333. 2007. View Article : Google Scholar : PubMed/NCBI
19	Li XY, He JL, Liu HT, Li WM and Yu C: Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways. J Ethnopharmacol. 125:83–89. 2009. View Article : Google Scholar : PubMed/NCBI
20	Gu Y, Zheng G, Xu M, et al: Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 120:147–156. 2012. View Article : Google Scholar : PubMed/NCBI
21	Yu F, Kamada H, Niizuma K, Endo H and Chan PH: Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 25:184–195. 2008. View Article : Google Scholar : PubMed/NCBI
22	Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, Prestopnik J, Wills J and Rosenberg GA: Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke. 42:1345–1350. 2011. View Article : Google Scholar : PubMed/NCBI
23	Vorbrodt AW and Dobrogowska DH: Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: Electron microscopist's view. Brain Res Brain Res Rev. 42:221–242. 2003. View Article : Google Scholar : PubMed/NCBI
24	Sandoval KE and Witt KA: Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 32:200–219. 2008. View Article : Google Scholar : PubMed/NCBI
25	Krizbai IA and Deli MA: Signalling pathways regulating the tight junction permeability in the blood-brain barrier. Cell Mol Biol (Noisy-le-grand). 49:23–31. 2003.PubMed/NCBI